Oncology Pioneer xCures Names Experts to Advisory Boards
Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)
We are partnering with this company (and Cancer Commons) to track the patients in our Onc-201 compassionate use program. We are testing a program that will allow our patients to utilize xCures' services at no cost to the patients or to the Musella Foundation. xCures will evaluate a patient’s case, figure out the best treatment options using a combination of artificial intelligence, nurse navigators, research scientists, internal tumor board and an external virtual tumor board. xCures will then present the options to the patient who then decides with their own medical team which option to pursue. xCures will then help them get access to the treatments if needed, and then follow up to see how it works out, both to add knowledge to their knowledge base and to help again if there is a recurrence.
Disclaimer: I am a paid consultant for this company and I am an investor.
Posted on: 10/10/2019
Click HERE to return to brain tumor news headlines